Literature DB >> 26421118

Non-steroidal Anti-inflammatory Drugs (NSAIDs) Use in Primary Health Care Centers in A'Seeb, Muscat: A Clinical Audit.

Asma Al-Shidhani1, Naama Al-Rawahi1, Abdulhakeem Al-Rawahi2.   

Abstract

OBJECTIVE: We sought to assess the trend of non-steroidal anti-inflammatory drug (NSAID) use in primary health care institutions located in A'Seeb, a province in the capital city of Oman, Muscat. Additionally, we evaluated the relationship between a physician's years of experience and the number of prescription issued, as well as the presence of risk factors and side effects in the patients who received these prescriptions.
METHOD: A clinical audit was conducted in four primary health care centers in the Muscat region over a one-week period in April 2014. The target population included patients aged 18 years or over who attended one of the four health centers and were prescribed NSAIDs. Overall, 272 patients were recruited by systematic random sampling. The data were collected by two methods: direct face-to-face interviews and evaluations of the patient's electronic medical file. The prescribing doctors were blind to the audit. The collected information included patients demographics, past and current medical history of related comorbidities, NSAID type, dose, duration and indications for use, concomitant warfarin or/and aspirin prescriptions, and co-prescription of gastroprotective agents.
RESULTS: In total, 15% of patients received an NSAID prescription: females were issued more prescriptions than males. The percentage of patients who received an NSAID prescription across the health centers ranged from 9% to 24%. The main reason for prescribing NSAIDs was musculoskeletal problems. The most frequently prescribed NSAID was ibuprofen. Sixteen percent of patients who received an NSAID prescription had a risk factor related to its use. The mean and median duration of the NSAID prescriptions of all types were 5.6 and 5.0 days, respectively. Physicians with a greater number of years experience prescribed more NSAIDs.
CONCLUSION: Our study showed that the number of prescriptions of NSAIDs among various institutes varied, which could reflect the level of awareness concerning NSAID risks among the prescribing doctors. NSAIDs were prescribed for patients with comorbidities and patients with previously documented side effects without considering protective agents. Therefore, we suggest that the use of these medications is controlled, especially in high-risk populations.

Entities:  

Keywords:  Anti-Inflammatory Agents, Non-Steroidal; NSAIDs; Prescriptions; side effects; utilization

Year:  2015        PMID: 26421118      PMCID: PMC4576381          DOI: 10.5001/omj.2015.73

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  22 in total

1.  Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole.

Authors:  David Y Graham; Naurang M Agrawal; Donald R Campbell; Marian M Haber; Cyndy Collis; Nancy L Lukasik; Bidan Huang
Journal:  Arch Intern Med       Date:  2002-01-28

Review 2.  Topical NSAIDs for chronic musculoskeletal pain in adults.

Authors:  Sheena Derry; R Andrew Moore; Roy Rabbie
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

3.  A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.

Authors:  A N Price-Forbes; R Callaghan; M E Allen; I F Rowe
Journal:  Rheumatology (Oxford)       Date:  2005-04-12       Impact factor: 7.580

4.  Study of usage pattern of nonsteroidal anti-inflammatory drugs (NSAIDs) among different practice categories in Indian clinical setting.

Authors:  A D Paul; C K Chauhan
Journal:  Eur J Clin Pharmacol       Date:  2004-12-17       Impact factor: 2.953

5.  Pharmacoepidemiological study of prescription pattern of analgesics, antipyretics, and nonsteroidal anti-inflammatory drugs at a tertiary health care center.

Authors:  Mohammed A Al-Homrany; Yacoub M Irshaid
Journal:  Saudi Med J       Date:  2007-03       Impact factor: 1.484

6.  Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis.

Authors:  A G Johnson; T V Nguyen; R O Day
Journal:  Ann Intern Med       Date:  1994-08-15       Impact factor: 25.391

7.  Adherence to proton pump inhibitors or H2-receptor antagonists during the use of non-steroidal anti-inflammatory drugs.

Authors:  M C J M Sturkenboom; T A Burke; M J D Tangelder; J P Dieleman; S Walton; J L Goldstein
Journal:  Aliment Pharmacol Ther       Date:  2003-12       Impact factor: 8.171

Review 8.  Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond.

Authors:  Praveen Rao; Edward E Knaus
Journal:  J Pharm Pharm Sci       Date:  2008-09-20       Impact factor: 2.327

9.  A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure.

Authors:  J E Pope; J J Anderson; D T Felson
Journal:  Arch Intern Med       Date:  1993-02-22

Review 10.  Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies.

Authors:  Patricia McGettigan; David Henry
Journal:  PLoS Med       Date:  2011-09-27       Impact factor: 11.069

View more
  5 in total

1.  Comparison of the Effect of Stretching Exercises and Mefenamic Acid on the Reduction of Pain and Menstruation Characteristics in Primary Dysmenorrhea: A Randomized Clinical Trial.

Authors:  Narges Motahari-Tabari; Marjan Ahmad Shirvani; Abbas Alipour
Journal:  Oman Med J       Date:  2017-01

2.  The Efficacy of Zinc Administration in the Treatment of Primary Dysmenorrhea.

Authors:  Batool Teimoori; Marzieh Ghasemi; Zeinab Sadat Amir Hoseini; Maryam Razavi
Journal:  Oman Med J       Date:  2016-03

3.  Frequency and Associations of Prescription Nonsteroidal Anti-inflammatory Drug Use Among Patients With a Musculoskeletal Disorder and Hypertension, Heart Failure, or Chronic Kidney Disease.

Authors:  Zachary Bouck; Graham C Mecredy; Noah M Ivers; Moumita Barua; Danielle Martin; Peter C Austin; Joshua Tepper; R Sacha Bhatia
Journal:  JAMA Intern Med       Date:  2018-11-01       Impact factor: 21.873

4.  Preclinical Pharmacokinetics and Acute Toxicity in Rats of 5-{[(2E)-3-Bromo-3-carboxyprop-2-enoyl]amino}-2-hydroxybenzoic Acid: A Novel 5-Aminosalicylic Acid Derivative with Potent Anti-Inflammatory Activity.

Authors:  Mara Gutiérrez-Sánchez; Aurelio Romero-Castro; José Correa-Basurto; Martha Cecilia Rosales-Hernández; Itzia Irene Padilla-Martínez; Jessica Elena Mendieta-Wejebe
Journal:  Molecules       Date:  2021-11-11       Impact factor: 4.411

5.  Trends in Ambulatory Analgesic Usage after Myocardial Infarction: A Nationwide Cross-Sectional Study of Real-World Data.

Authors:  Sun-Young Jung; Seung Yeon Song; Eunyoung Kim
Journal:  Healthcare (Basel)       Date:  2022-02-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.